Literature DB >> 7565780

Genetic enhancement of RNA-processing defects by a dominant mutation in B52, the Drosophila gene for an SR protein splicing factor.

X Peng1, S M Mount.   

Abstract

SR proteins are essential for pre-mRNA splicing in vitro, act early in the splicing pathway, and can influence alternative splice site choice. Here we describe the isolation of both dominant and loss-of-function alleles of B52, the gene for a Drosophila SR protein. The allele B52ED was identified as a dominant second-site enhancer of white-apricot (wa), a retrotransposon insertion in the second intron of the eye pigmentation gene white with a complex RNA-processing defect. B52ED also exaggerates the mutant phenotype of a distinct white allele carrying a 5' splice site mutation (wDR18), and alters the pattern of sex-specific splicing at doublesex under sensitized conditions, so that the male-specific splice is favored. In addition to being a dominant enhancer of these RNA-processing defects, B52ED is a recessive lethal allele that fails to complement other lethal alleles of B52. Comparison of B52ED with the B52+ allele from which it was derived revealed a single change in a conserved amino acid in the beta 4 strand of the first RNA-binding domain of B52, which suggests that altered RNA binding is responsible for the dominant phenotype. Reversion of the B52ED dominant allele with X rays led to the isolation of a B52 null allele. Together, these results indicate a critical role for the SR protein B52 in pre-mRNA splicing in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565780      PMCID: PMC230879          DOI: 10.1128/MCB.15.11.6273

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

1.  Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing.

Authors:  R H Diamond; K Du; V M Lee; K L Mohn; B A Haber; D S Tewari; R Taub
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

Review 2.  hnRNP proteins and the biogenesis of mRNA.

Authors:  G Dreyfuss; M J Matunis; S Piñol-Roma; C G Burd
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  RNA splicing. Question of commitment.

Authors:  J Manley
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

4.  U2AF homolog required for splicing in vivo.

Authors:  J Potashkin; K Naik; K Wentz-Hunter
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

5.  Specific commitment of different pre-mRNAs to splicing by single SR proteins.

Authors:  X D Fu
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

6.  A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA.

Authors:  M Tian; T Maniatis
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

7.  The Drosophila RNA-binding protein RBP1 is localized to transcriptionally active sites of chromosomes and shows a functional similarity to human splicing factor ASF/SF2.

Authors:  Y J Kim; P Zuo; J L Manley; B S Baker
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

8.  Functional domains of the human splicing factor ASF/SF2.

Authors:  P Zuo; J L Manley
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

9.  Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.

Authors:  J F Cáceres; A R Krainer
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

10.  Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.

Authors:  I C Eperon; D C Ireland; R A Smith; A Mayeda; A R Krainer
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  22 in total

1.  Trans-acting factors required for inclusion of regulated exons in the Ultrabithorax mRNAs of Drosophila melanogaster.

Authors:  J M Burnette; A R Hatton; A J Lopez
Journal:  Genetics       Date:  1999-04       Impact factor: 4.562

2.  Evidence for splice site pairing via intron definition in Schizosaccharomyces pombe.

Authors:  C M Romfo; C J Alvarez; W J van Heeckeren; C J Webb; J A Wise
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Pre-mRNA splicing by the essential Drosophila protein B52: tissue and target specificity.

Authors:  B E Hoffman; J T Lis
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Negative feedback regulation among SR splicing factors encoded by Rbp1 and Rbp1-like in Drosophila.

Authors:  Supriya Kumar; A Javier Lopez
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

5.  Functional properties of p54, a novel SR protein active in constitutive and alternative splicing.

Authors:  W J Zhang; J Y Wu
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.

Authors:  J Wang; S H Xiao; J L Manley
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

7.  smg mutants affect the expression of alternatively spliced SR protein mRNAs in Caenorhabditis elegans.

Authors:  M Morrison; K S Harris; M B Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

8.  Alternative splicing and trans-splicing events revealed by analysis of the Bombyx mori transcriptome.

Authors:  Wei Shao; Qiong-Yi Zhao; Xiu-Ye Wang; Xin-Yan Xu; Qing Tang; Muwang Li; Xuan Li; Yong-Zhen Xu
Journal:  RNA       Date:  2012-05-24       Impact factor: 4.942

9.  RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins.

Authors:  S D Chandler; A Mayeda; J M Yeakley; A R Krainer; X D Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

10.  Mutations in the small subunit of the Drosophila U2AF splicing factor cause lethality and developmental defects.

Authors:  D Z Rudner; R Kanaar; K S Breger; D C Rio
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.